353 related articles for article (PubMed ID: 25008787)
1. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
[TBL] [Abstract][Full Text] [Related]
2. Screening for lupus anticoagulants in patients treated with vitamin K antagonists.
Isert M; Miesbach W; Stoever G; Lindhoff-Last E; Linnemann B
Int J Lab Hematol; 2015 Dec; 37(6):758-65. PubMed ID: 26224222
[TBL] [Abstract][Full Text] [Related]
3. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
Ieko M; Naito S; Yoshida M
Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
[TBL] [Abstract][Full Text] [Related]
4. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
5. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
[TBL] [Abstract][Full Text] [Related]
6. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
[TBL] [Abstract][Full Text] [Related]
7. Mixing studies in lupus anticoagulant testing are required at least in some type of samples.
Devreese KM; de Laat B
J Thromb Haemost; 2015 Aug; 13(8):1475-8. PubMed ID: 26017873
[TBL] [Abstract][Full Text] [Related]
8. Frequent false-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin.
Martinuzzo ME; Barrera LH; D 'adamo MA; Otaso JC; Gimenez MI; Oyhamburu J
Int J Lab Hematol; 2014 Apr; 36(2):144-50. PubMed ID: 24034808
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
[TBL] [Abstract][Full Text] [Related]
10. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
Hong SK; Hwang SM; Kim JE; Kim HK
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
[TBL] [Abstract][Full Text] [Related]
12. Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays.
Pradella P; Azzarini G; Santarossa L; Caberlotto L; Bardin C; Poz A; D'Aurizio F; Giacomello R
Clin Chem Lab Med; 2013 Feb; 51(2):379-85. PubMed ID: 23001319
[TBL] [Abstract][Full Text] [Related]
13. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.
Depreter B; Devreese KM
Clin Chem Lab Med; 2016 Sep; 54(9):1511-6. PubMed ID: 26894579
[TBL] [Abstract][Full Text] [Related]
14. Impact of different preanalytical conditions on results of lupus anticoagulant tests.
Kristoffersen AH; Hammer IJ; Vannes S; Åsberg A; Aakre KM
Int J Lab Hematol; 2019 Dec; 41(6):745-753. PubMed ID: 31549775
[TBL] [Abstract][Full Text] [Related]
15. To mix or not to mix in lupus anticoagulant testing? That is the question.
Tripodi A
Semin Thromb Hemost; 2012 Jun; 38(4):385-9. PubMed ID: 22618530
[TBL] [Abstract][Full Text] [Related]
16. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
Jennings I; Kitchen S; Woods TA; Preston FE; Greaves M
Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
[TBL] [Abstract][Full Text] [Related]
17. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
[TBL] [Abstract][Full Text] [Related]
18. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
Exner T; Low J
Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
[TBL] [Abstract][Full Text] [Related]
19. In ECAT veritas?
Reber G; Meijer P
Lupus; 2012 Jun; 21(7):722-4. PubMed ID: 22635212
[TBL] [Abstract][Full Text] [Related]
20. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.
Arachchillage DR; Mackie IJ; Efthymiou M; Isenberg DA; Machin SJ; Cohen H
J Thromb Haemost; 2015 Jul; 13(7):1264-73. PubMed ID: 25850997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
